ストックスクリーナーアプリを入手
4.22
2.09%
-0.09
アフターアワーズ：
4.22
前日終値:
$4.31
開ける：
$4.28
24時間の取引高:
608.39K
Relative Volume:
0.45
時価総額：
$544.98M
収益：
$204.17M
当期純損益:
$-74.00M
株価収益率:
-7.3074
EPS:
-0.5775
ネットキャッシュフロー:
$-12.84M
1週間 パフォーマンス:
-5.38%
1か月 パフォーマンス:
-4.74%
6か月 パフォーマンス:
-15.60%
1年 パフォーマンス:
+17.22%
1日の値動き範囲:
$4.135
$4.31
1週間の範囲:
$4.135
$4.565
52週間の値動き範囲:
$3.28
$6.18
Cytek Biosciences Inc Stock (CTKB) Company Profile
名前
Cytek Biosciences Inc
セクター
電話
(877) 922-9835
住所
47215 LAKEVIEW BOULEVARD, FREMONT
Compare CTKB vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
4.22 | 569.52M | 204.17M | -74.00M | -12.84M | -0.5775 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-02 | 再開されました | Morgan Stanley | Equal-Weight |
| 2025-05-09 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-01-31 | ダウングレード | Goldman | Buy → Sell |
| 2023-12-14 | 開始されました | Stephens | Overweight |
| 2023-07-19 | 開始されました | Raymond James | Mkt Perform |
| 2022-01-06 | 再開されました | Piper Sandler | Overweight |
すべてを表示
Cytek Biosciences Inc (CTKB) 最新ニュース
Cytek Biosciences, Inc. Revenue Breakdown – TRADEGATE:8EQ - TradingView
Cytek Biosciences Inc (CTKB) Cash Flow - TradingKey
Cytek Biosciences Inc (CTKB) Valuation: PE, PB & Fair Value Analysis - TradingKey
CTKB|Cytek Biosciences Inc|Price:4.420|Chg%:-0.040 - TradingKey
Cytek Biosciences, Inc. Revenue Breakdown – FWB:8EQ - TradingView
Cytek Biosciences Inc (CTKB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cytek Biosciences Inc (CTKB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cytek Biosciences Inc (CTKB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cytek Biosciences CEO advances flow cytometry for informed healthcare decision making - Traders Union
CSBR vs. CTKB: Which Life Sciences Stock Has Better Long-Term Upside? - TradingView
CTKB stock rises as Cytek BioSciences reports revenue and margin trends - Ad-hoc-news.de
Cytek Biosciences to report Q2 2026 results on August 5 - scanx.trade
Cytek Biosciences sets Q2 results call for 4:30 p.m. ET Aug. 5 - Stock Titan
Cytek Biosciences to Report Second Quarter 2026 Financial Results on August 5, 2026 - Moomoo
Cytek Biosciences reveals special summer incentive for reagent customers - Traders Union
Cytek Bio stock trades steadily as Q1 2026 growth and margin profile frame investor focus - Ad-hoc-news.de
Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement - BioSpace
Cytek Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement - Finviz
Cytek Biosciences Opens Innovation Center in Washington - marketscreener.com
Cytek Biosciences Opens Bellevue Innovation Center to Advance R&D and Customer Engagement - Quiver Quantitative
Cytek's Valerie Barnett exits as Chief Legal Officer; consulting role agreed - TradingView
Cytek Biosciences (Nasdaq: CTKB) sets severance and consulting terms - Stock Titan
BlackRock, Inc. Reduces Stake in Cytek Biosciences Inc - GuruFocus
Cytek Biosciences announces webinar on accelerating human T-cell biology research - Traders Union
BlackRock (NYSE: CTKB) holds 7.2% — 9.36M shares of Cytek Biosciences - Stock Titan
Cytek Biosciences expands flow cytometry footprint amid growing immunology demand - Ad-hoc-news.de
CTKBCytek BioSciences Inc Latest SEC Filings - Finviz
If You Invested $1,000 in Cytek Biosciences, Inc. (CTKB) - Stock Titan
Cytek Biosciences explores growth paths as investors weigh long-term potential - ad-hoc-news.de
Cytek Biosciences (CTKB) Edges Higher as Shares Stabilize Near SupportWeekly Profile - dars.gov.et
June 2026 Penny Stocks With Promising Potential - Sahm
Cytek Biosciences (NASDAQ: CTKB) adds Chief Legal Officer as reporting insider - Stock Titan
Cytek Biosciences, Inc.(NasdaqGS: CTKB) dropped from Russell 2000 Defensive Index - marketscreener.com
Enterprise value to revenue forward of Cytek Biosciences, Inc. – NASDAQ:CTKB - TradingView
Price to earnings forward of Cytek Biosciences, Inc. – NASDAQ:CTKB - TradingView
Enterprise value to EBIT forward of Cytek Biosciences, Inc. – NASDAQ:CTKB - TradingView
Price to sales forward of Cytek Biosciences, Inc. – NASDAQ:CTKB - TradingView
Cytek Biosciences, Inc.(NasdaqGS:CTKB) dropped from Russell 2000 Value-Defensive Index - marketscreener.com
Enterprise value to revenue forward of Cytek Biosciences, Inc. – BOATS:CTKB - TradingView
Cytek Biosciences (CTKB) Holds Steady Near Support as Volume Tells the StoryLiquidity Sweep - dars.gov.et
CTKB Forecast — Price Target — Prediction for 2027 - TradingView
8EQ Forecast — Price Target — Prediction for 2027 - TradingView
Cytek Biosciences, Inc. Actuals & Estimates (NASDAQ:CTKB) - TradingView
Cytek Biosciences Announces Chief Legal Officer Transition - The Globe and Mail
Cytek Biosciences, Inc. Actuals & Estimates (GETTEX:8EQ) - TradingView
Cytek Biosciences' Valerie Barnett to Depart as Chief Legal Officer and Corporate Secretary - TradingView
Cytek Biosciences (NASDAQ: CTKB) legal chief exit detailed - Stock Titan
Cytek Biosciences, Inc. Announces Termination of Valerie Barnett as Chief Legal Officer and Corporate Secretary, Effective June 29, 2026 - marketscreener.com
Cytek Biosciences, Inc.(NasdaqGS: CTKB) dropped from S&P 1000 - marketscreener.com
Cytek Biosciences, Inc.(NasdaqGS: CTKB) dropped from S&P 600 Health Care - marketscreener.com
Cytek Biosciences, Inc.(NasdaqGS: CTKB) dropped from S&P Composite 1500 - marketscreener.com
Cytek Biosciences Inc (CTKB) 財務データ
収益
当期純利益
現金流量
EPS
1.04%
11.95%
大文字化:
|
ボリューム (24 時間):